TQB3525 for Advanced Bone Sarcomas With PI3KA Mutations or PTEN Loss

Clinical trial NCT04690725 · UNKNOWN

Trial details

NCT number: NCT04690725
Sponsor: Peking University People's Hospital
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Safety Issues Efficacy, Self

Start date: 2020-10-01
Primary completion: 2022-01-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.